TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Common stock, $0.0001 par value
Symbol
TLSI on Nasdaq
Shares outstanding
49,883,741
Price per share
$4.99
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
11,407,711
Total reported value
$79,628,749
% of total 13F portfolios
0%
Share change
+1,697,619
Value change
+$12,128,066
Number of holders
62
Price from insider filings
$4.99
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Frankenius Equity AB 14% -31% $34,179,868 +$1,257,864 6,989,748 +3.8% Frankenius Equity AB 31 Jul 2025
Utmost Group Plc 6.8% $15,741,343 +$6,438,609 3,385,235 +69% Utmost Group PLC 30 Sep 2025
Wahlstrom Mats 6% -33% $14,610,738 +$931,271 2,987,881 +6.8% Mats Wahlstrom 31 Jul 2025
Nantahala Capital Management, LLC 4.1% -24% $9,487,139 +$187,139 2,040,245 +2% Nantahala Capital Management, LLC 30 Sep 2025

As of 31 Dec 2025, 62 institutional investors reported holding 11,407,711 shares of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI). This represents 23% of the company’s total 49,883,741 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) together control 22% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 4.2% 2,070,827 +1.5% 0.86% $14,454,372
BlackRock, Inc. 3.1% 1,534,336 +95% 0% $10,709,665
VANGUARD GROUP INC 3.1% 1,530,707 +32% 0% $10,684,335
AWM Investment Company, Inc. 2.5% 1,243,780 -0.5% 0.84% $8,681,584
GILDER GAGNON HOWE & CO LLC 2% 979,023 -6.5% 0.07% $6,833,581
GEODE CAPITAL MANAGEMENT, LLC 1.5% 751,207 +35% 0% $5,245,335
Wealthcare Advisory Partners LLC 1.3% 643,740 0% 0.09% $4,493,305
Alyeska Investment Group, L.P. 0.82% 407,500 -27% 0.01% $2,844,350
MORGAN STANLEY 0.73% 365,255 +1932% 0% $2,549,481
STATE STREET CORP 0.53% 264,628 +37% 0% $1,847,103
NORTHERN TRUST CORP 0.45% 222,234 +26% 0% $1,551,194
BANK OF AMERICA CORP /DE/ 0.4% 198,016 +4.7% 0% $1,382,152
KOTLER KEVIN 0.29% 145,200 0% 0.75% $1,013,496
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.2% 100,077 +75% 0% $698,537
Empire Financial Management Company, LLC 0.14% 72,027 0.11% $502,748
CWA Asset Management Group, LLC 0.14% 72,000 0% 0.02% $502,560
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.14% 69,500 0% 0.01% $485,110
GOLDMAN SACHS GROUP INC 0.13% 65,968 -56% 0% $460,456
Bank of New York Mellon Corp 0.13% 64,604 +38% 0% $450,934
WHITE PINE CAPITAL LLC 0.12% 58,551 -2% 0.11% $408,686
BARCLAYS PLC 0.1% 47,699 +80% 0% $332,939
Squarepoint Ops LLC 0.09% 44,371 -40% 0% $309,710
MSD Partners, L.P. 0.08% 39,999 0% 0.26% $279,193
Nuveen, LLC 0.07% 36,550 +77% 0% $255,119
MILLENNIUM MANAGEMENT LLC 0.07% 35,679 +0.19% 0% $249,039

Institutional Holders of TriSalus Life Sciences, Inc. - Common stock, $0.0001 par value (TLSI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 11,407,711 $79,628,749 +$12,128,066 $6.98 62
2025 Q3 9,563,230 $44,470,060 +$5,042,569 $4.65 54
2025 Q2 8,470,104 $46,161,422 +$30,072,898 $5.45 46
2025 Q1 2,947,768 $16,271,736 +$3,567,159 $5.52 33
2024 Q4 2,345,660 $11,752,144 +$904,681 $5.01 28
2024 Q3 2,171,190 $10,009,408 +$2,041,090 $4.61 31
2024 Q2 1,617,489 $8,929,169 +$3,605,411 $5.52 26
2024 Q1 925,707 $9,026,910 +$2,616,406 $9.75 24
2023 Q4 679,602 $5,741,892 +$4,363,853 $8.45 19
2023 Q3 136,575 $699,263 +$699,263 $5.12 9